Quick Answer
STRATA Skin Sciences, Inc. reported Operating Income Loss of -$4.70 million for the year ending 2025.
- STRATA Skin Sciences, Inc. showed an increase of +49.2% in Operating Income Loss from 2024 to 2025.
- This data is from STRATA Skin Sciences, Inc.'s annual report (Form 10-K), filed with the SEC on March 26, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 17 years of available data (2009 to 2025), STRATA Skin Sciences, Inc.'s Operating Income Loss has grown by 74.7%.
- Historical annual values: Fiscal year 2025: -$4.70 million | Fiscal year 2024: -$9.26 million | Fiscal year 2023: -$8.60 million | Fiscal year 2022: -$4.65 million | Fiscal year 2021: -$4.40 million | Fiscal year 2020: -$4.08 million | Fiscal year 2019: -$3.01 million | Fiscal year 2018: -$3.36 million | Fiscal year 2017: -$1.80 million | Fiscal year 2016: -$3.60 million | Fiscal year 2015: -$16.48 million | Fiscal year 2014: -$16.62 million | Fiscal year 2013: -$24.13 million | Fiscal year 2012: -$22.73 million | Fiscal year 2011: -$20.46 million | Fiscal year 2010: -$20.23 million | Fiscal year 2009: -$18.58 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: